ABSTRACT
Elevated homocysteine (Hcy) levels are detrimental to neuronal cells and contribute to cognitive dysfunction in rats. Mitochondria plays a crucial role in cellular energy metabolism. Interestingly, the damaging effects of Hcy in vivo and in vitro conditions exhibit distinct results. Herein, we aimed to investigate the effects of Hcy on mitochondrial function in primary neurons and PC12 cells and explore the underlying mechanisms involved. The metabolic intermediates of Hcy act as methyl donors and play important epigenetic regulatory roles. N6-methyldeoxyadenosine (6 mA) modification, which is enriched in mitochondrial DNA (mtDNA), can be mediated by methylase METTL4. Our study suggested that mitochondrial perturbation caused by Hcy in primary neurons and PC12 cells may be attributable to mtDNA 6 mA modification difference. Hcy could activate the expression of METTL4 within mitochondria to facilitate mtDNA 6 mA status, and repress mtDNA transcription, then result in mitochondrial dysfunction.
Subject(s)
Deoxyadenosines , Hippocampus , Homocysteine , Mitochondria , Neurons , Animals , Rats , PC12 Cells , Neurons/metabolism , Neurons/drug effects , Homocysteine/pharmacology , Homocysteine/analogs & derivatives , Homocysteine/metabolism , Mitochondria/metabolism , Mitochondria/drug effects , Deoxyadenosines/pharmacology , Hippocampus/metabolism , Hippocampus/drug effects , Rats, Sprague-Dawley , DNA, Mitochondrial/metabolism , DNA, Mitochondrial/genetics , Cells, Cultured , Methyltransferases/metabolism , Methyltransferases/geneticsABSTRACT
Elevated homocysteine (Hcy) levels have been recognized as significant risk factor for cardiovascular and cerebrovascular diseases, closely related to endothelial injury. While expression of Ciliary Neurotrophic Factor (CNTF) significantly increases during Hcy-induced vascular endothelial cell injury, the precise molecular pathways through which CNTF operates remain to be clarified. To induce vascular endothelial cell injury, human umbilical vein endothelial cells (HUVECs) were treated with Hcy. Cell viability and apoptosis in HUVECs were assessed using the CCK-8 assay and flow cytometry. Western blot analysis determined the expression levels of the JAK2-STAT3 pathway, inflammation-related factors (IL-1ß, NLRP3, ICAM-1, VCAM-1), and apoptosis-related factors (cleaved Caspase-3 and Bax). Immunofluorescence staining and western blotting were employed to examine CD31 and α-SMA expression. Knockdown of CNTF was achieved using lentiviral interference, and its effects on inflammation and cell injury were evaluated. Chromatin immunoprecipitation (ChIP) and dual luciferase reporter analysis were conducted to investigate the interaction between the MAFK and CNTF promoters. Our results indicated that Hcy induced high expression of CNTF and activated the JAK2-STAT3 signaling pathway, thereby upregulating factors associated with inflammation and cell apoptosis. Inhibiting CNTF alleviated Hcy-induced inflammation and cell injury. MAFK was identified as a transcription factor promoting CNTF transcription, and its overexpression exacerbated inflammation and cell injury in Hcy-treated HUVECs through the CNTF-JAK2-STAT3 axis, which could be reversed by knocking down CNTF. Activation of MAFK leads to CNTF upregulation, which activates the JAK2-STAT3 signaling pathway, regulating inflammation and inducing injury in Hcy-exposed vascular endothelial cells. Targeting CNTF or its upstream regulator MAFK may represent potential therapeutic strategies for mitigating endothelial dysfunction associated with hyperhomocysteinemia and cardiovascular diseases.
Subject(s)
Apoptosis , Ciliary Neurotrophic Factor , Homocysteine , Human Umbilical Vein Endothelial Cells , Inflammation , Janus Kinase 2 , STAT3 Transcription Factor , Signal Transduction , Janus Kinase 2/metabolism , Humans , STAT3 Transcription Factor/metabolism , Homocysteine/pharmacology , Homocysteine/metabolism , Human Umbilical Vein Endothelial Cells/metabolism , Inflammation/metabolism , Inflammation/pathology , Ciliary Neurotrophic Factor/metabolism , Ciliary Neurotrophic Factor/genetics , Apoptosis/drug effects , Cells, Cultured , Cell Survival/drug effectsABSTRACT
BACKGROUND: Abnormally elevated homocysteine (Hcy) is recognized as a biomarker and risk factor for Alzheimer's disease (AD). However, the underlying mechanisms by which Hcy affects AD are still unclear. OBJECTIVES: This study aimed to elucidate the effects and mechanisms by which Hcy affects AD-like pathological changes in the hippocampus through in vivo and in vitro experiments, and to investigate whether folic acid (FA) and S-adenosylmethionine (SAM) supplementation could improve neurodegenerative injuries. METHODS: In vitro experiments hippocampal neurons of rat were treated with Hcy, FA or SAM for 24 h; while the hyperhomocysteinemia (HHcy) in Wistar rats was established by intraperitoneal injection of Hcy, and FA was added to feed. The expression of ß-amyloid (Aß), phosphorylated tau protein, presenilin 1 (PS1) at the protein level and the activity of protein phosphatase 2A (PP2A) were detected, the immunopositive cells for Aß and phosphorylated tau protein in the rat hippocampus were also evaluated by immunohistochemical staining. RESULTS: FA and SAM significantly repressed Hcy-induced AD-like pathological changes in the hippocampus, including the increased tau protein phosphorylation at Ser214, Ser396 and the expression of Aß42. In addition, Hcy-induced PS1 expression increased at the protein level and PP2A activity decreased, while FA and SAM were able to retard that. CONCLUSIONS: The increase in PS1 expression and decrease in PP2A activity may be the mechanisms underlying the Hcy-induced AD-like pathology. FA and SAM significantly repressed the Hcy-induced neurodegenerative injury by modulating PS1 and PP2A methylation levels.
Subject(s)
Alzheimer Disease , Amyloid beta-Peptides , Folic Acid , Hippocampus , Homocysteine , Presenilin-1 , Protein Phosphatase 2 , Rats, Wistar , S-Adenosylmethionine , tau Proteins , Animals , Hippocampus/drug effects , Hippocampus/metabolism , Hippocampus/pathology , Protein Phosphatase 2/metabolism , S-Adenosylmethionine/pharmacology , Alzheimer Disease/pathology , Alzheimer Disease/metabolism , Alzheimer Disease/chemically induced , Homocysteine/pharmacology , Homocysteine/toxicity , Folic Acid/pharmacology , Rats , Male , Presenilin-1/genetics , tau Proteins/metabolism , Amyloid beta-Peptides/metabolism , Methylation/drug effects , Hyperhomocysteinemia/metabolism , Hyperhomocysteinemia/chemically induced , Neurons/drug effects , Neurons/metabolism , Neurons/pathology , Phosphorylation/drug effects , Disease Models, AnimalABSTRACT
Elevated homocysteine (Hcy) levels, referred to hyperhomocysteinemia, are associated with an increased risk of several neurological disorders. Ferroptosis and inflammation play a vital role in Hcy-induced neuronal dysfunction. Amentoflavone (AMF), an active natural biflavone compound, exhibits antioxidative, anti-inflammatory, and neuroprotective activities. This study aimed to explore the potential effects of AMF on Hcy-induced neuronal injury, with a particular focus on the underlying mechanisms involving ferroptosis and inflammation. We assessed neuronal damage in HT22 cells by measuring cell viability, lactate dehydrogenase (LDH) release, and proliferation rates. Additionally, we evaluated oxidative stress markers including the levels of reactive oxygen species (ROS), MitoSOX, mitochondrial membrane potential (MMP), malondialdehyde (MDA), and glutathione (GSH). Iron metabolism and ferroptosis-related gene expressions (Ptgs2, Tfr1, and Fth1) were quantified. TheSLC7A11/GPX4 axis was also detected. Our results showed that AMF treatment dramatically mitigated Hcy-induced neuronal injury by increasing cell viability, decreasing LDH release, and promoting cell proliferation. AMF treatment also reduced Hcy-induced oxidative stress and lipid peroxidation, as evidenced by reduced ROS, MitoSOX, MMP, and MDA levels, along with an increased GSH content in HT22 cells. In addition, AMF treatment reduced iron content and ferroptosis-related gene mRNA levels. However, Erastin, a ferroptosis inducer, blocked these neuroprotective effects of AMF. Ferroptosis inhibitor Ferrostatin-1 also attenuated Hcy-induced ferroptosis. Moreover, both AMF and Ferrostatin-1 effectively mitigated Hcy-induced inflammation, which was again antagonized by Erastin. Mechanistically, AMF treatment enhanced SLC7A11/GPX4 axis in Hcy-treated HT22 cells. In conclusion, these findings suggest that AMF possesses neuroprotection against Hcy-induced injury primarily by inhibiting ferroptosis-mediated inflammation, partly through the activation of SLC7A11/GPX4 axis.
Subject(s)
Amino Acid Transport System y+ , Biflavonoids , Ferroptosis , Homocysteine , Neurons , Phospholipid Hydroperoxide Glutathione Peroxidase , Ferroptosis/drug effects , Ferroptosis/physiology , Biflavonoids/pharmacology , Animals , Mice , Homocysteine/pharmacology , Neurons/drug effects , Neurons/metabolism , Phospholipid Hydroperoxide Glutathione Peroxidase/metabolism , Amino Acid Transport System y+/metabolism , Oxidative Stress/drug effects , Neuroprotective Agents/pharmacology , Cell Line , Inflammation/metabolism , Inflammation/drug therapy , Reactive Oxygen Species/metabolism , Cell Survival/drug effects , Cell Survival/physiologyABSTRACT
OBJECTIVES: Investigation of chronic homocysteine action on the excitability and N-methyl-D-aspartate (NMDA) sensitivity of the peripheral trigeminovascular system of rats. BACKGROUND: Migraine is a neurological disease that affects 15%-20% of the general population. Epidemiological observations show that an increase of the sulfur-containing amino acid homocysteine in plasma-called hyperhomocysteinemia-is associated with a high risk of migraine, especially migraine with aura. In animal studies, rats with hyperhomocysteinemia demonstrated mechanical allodynia, photophobia, and anxiety, and higher sensitivity to cortical spreading depression. In addition, rats with hyperhomocysteinemia were more sensitive in a model of chronic migraine induced by nitroglycerin which indicated the involvement of peripheral nociceptive mechanisms. The present work aimed to analyze the excitability of meningeal afferents and neurons isolated from the trigeminal ganglion of rats with prenatal hyperhomocysteinemia. METHODS: Experiments were performed on male rats born from females fed with a methionine-rich diet before and during pregnancy. The activity of meningeal afferents was recorded extracellularly in hemiskull preparations ex vivo and action potentials were characterized using cluster analysis. The excitability of trigeminal ganglion neurons was assessed using whole-cell patch clamp recording techniques and calcium imaging studies. Meningeal mast cells were stained using toluidine blue. RESULTS: The baseline extracellular recorded electrical activity of the trigeminal nerve was higher in the hyperhomocysteinemia group with larger amplitude action potentials. Lower concentrations of KCl caused an increase in the frequency of action potentials of trigeminal afferents recorded in rat hemiskull ex vivo preparations. In trigeminal ganglion neurons of rats with hyperhomocysteinemia, the current required to elicit at least one action potential (rheobase) was lower, and more action potentials were induced in response to stimulus of 2 × rheobase. In controls, short-term application of homocysteine and its derivatives increased the frequency of action potentials of the trigeminal nerve and induced Ca2+ transients in neurons, which are associated with the activation of NMDA receptors. At the same time, in rats with hyperhomocysteinemia, we did not observe an increased response of the trigeminal nerve to NMDA. Similarly, the parameters of Ca2+ transients induced by NMDA, homocysteine, and its derivatives were not changed in rats with hyperhomocysteinemia. Acute incubation of the meninges in homocysteine and homocysteinic acid did not change the state of the mast cells, whereas in the model of hyperhomocysteinemia, an increased degranulation of mast cells in the meninges was observed. CONCLUSIONS: Our results demonstrated higher excitability of the trigeminal system of rats with hyperhomocysteinemia. Together with our previous finding about the lower threshold of generation of cortical spreading depression in rats with hyperhomocysteinemia, the present data provide evidence of homocysteine as a factor that increases the sensitivity of the peripheral migraine mechanisms, and the control of homocysteine level may be an important strategy for reducing the risk and/or severity of migraine headache attacks.
Subject(s)
Homocysteine , Hyperhomocysteinemia , Meninges , Migraine Disorders , Trigeminal Ganglion , Animals , Hyperhomocysteinemia/complications , Hyperhomocysteinemia/physiopathology , Migraine Disorders/physiopathology , Migraine Disorders/metabolism , Male , Homocysteine/pharmacology , Rats , Trigeminal Ganglion/metabolism , Trigeminal Ganglion/physiopathology , Female , Disease Models, Animal , Action Potentials/physiology , Action Potentials/drug effects , Pregnancy , Rats, Wistar , Patch-Clamp Techniques , Rats, Sprague-Dawley , Neurons, Afferent/physiology , Neurons, Afferent/metabolismABSTRACT
Homocysteine, a sulfur-containing amino acid derived from methionine metabolism, is a known agonist of N-methyl-D-aspartate receptor (NMDAR) and is involved in neurotoxicity. Our previous findings showed that neuronal exposure to elevated homocysteine levels leads to sustained low-level increase in intracellular Ca2+, which is dependent on GluN2A subunit-containing NMDAR (GluN2A-NMDAR) stimulation. These studies further showed a role of ERK MAPK in homocysteine-GluN2A-NMDAR-mediated neuronal death. However, the intracellular mechanisms associated with such sustained GluN2A-NMDAR stimulation and subsequent Ca2+ influx have remained unexplored. Using live-cell imaging with Fluo3-AM and biochemical approaches, we show that homocysteine-GluN2A NMDAR-induced initial Ca2+ influx triggers sequential phosphorylation and subsequent activation of the proline rich tyrosine kinase 2 (Pyk2) and Src family kinases, which in turn phosphorylates GluN2A-Tyr1325 residue of GluN2A-NMDARs to maintain channel activity. The continuity of this cycle of events leads to sustained Ca2+ influx through GluN2A-NMDAR. Our findings also show that lack of activation of the regulatory tyrosine phosphatase STEP, which can limit Pyk2 and Src family kinase activity further contributes to the maintenance of this cycle. Additional studies using live-cell imaging of neurons expressing a redox-sensitive GFP targeted to the mitochondrial matrix show that treatment with homocysteine leads to a progressive increase in mitochondrial reactive oxygen species generation, which is dependent on GluN2A-NMDAR-mediated sustained ERK MAPK activation. This later finding demonstrates a novel role of GluN2A-NMDAR in homocysteine-induced mitochondrial ROS generation and highlights the role of ERK MAPK as the intermediary signaling pathway between GluN2A-NMDAR stimulation and mitochondrial reactive oxygen species generation.
Subject(s)
Homocysteine , Mitochondria , Reactive Oxygen Species , Receptors, N-Methyl-D-Aspartate , Receptors, N-Methyl-D-Aspartate/metabolism , Homocysteine/metabolism , Homocysteine/pharmacology , Reactive Oxygen Species/metabolism , Animals , Mitochondria/metabolism , Neurons/metabolism , Neurons/drug effects , Calcium/metabolism , Phosphorylation/drug effects , Focal Adhesion Kinase 2/metabolism , src-Family Kinases/metabolism , Rats , Mice , HumansABSTRACT
The emergence of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis (M. tuberculosis) has become a major medical problem. S-adenosyl-L-homocysteine hydrolase (MtSAHH) was selected as the target protein for the identification of novel anti-TB drugs. Dual hierarchical in silico Structure-Based Drug Screening was performed using a 3D compound structure library (with over 150 thousand synthetic chemicals) to identify compounds that bind to MtSAHH's active site. In vitro experiments were conducted to verify whether the nine compounds selected as new drug candidates exhibited growth-inhibitory effects against mycobacteria. Eight of the nine compounds that were predicted by dual hierarchical screening showed growth-inhibitory effects against Mycobacterium smegmatis (M. smegmatis), a model organism for M. tuberculosis. Compound 7 showed the strongest antibacterial activity, with an IC50 value of 30.2 µM. Compound 7 did not inhibit the growth of Gram-negative bacteria or exert toxic effects on human cells. Molecular dynamics simulations of 40 ns using the MtSAHH-Compound 7 complex structure suggested that Compound 7 interacts stably with the MtSAHH active site. These in silico and in vitro results suggested that Compound 7 is a promising lead compound for the development of new anti-TB drugs.
Subject(s)
Mycobacterium tuberculosis , Tuberculosis , Humans , Antitubercular Agents/chemistry , Drug Evaluation, Preclinical , Tuberculosis/microbiology , Homocysteine/pharmacology , Hydrolases/pharmacology , Molecular Docking SimulationABSTRACT
Elevated homocysteine (Hcy) levels have been linked to the development of cardiovascular diseases, notably endothelial dysfunction, a critical precursor to atherosclerosis. In this extensive investigation, we explore the intricate pathways through which Hcy influences endothelial dysfunction, with particular attention to the CXCL10/CXCR3 axis. Employing a dual approach encompassing both in vitro and in vivo models, we scrutinize the repercussions of Hcy exposure on endothelial functionality. Our results reveal that Hcy significantly impairs crucial endothelial processes, including cell migration, proliferation, and tube formation. Concomitantly, Hcy upregulates the expression of adhesion molecules, exacerbating endothelial dysfunction. In a murine hyperhomocysteinemia (HHcy) model, we observed a parallel increase in plasma Hcy levels and adverse vascular effects. Moreover, our study unraveled a pivotal role of the CXCL10/CXCR3 axis in Hcy-induced endothelial dysfunction. Hcy exposure led to the upregulation of CXCL10 and CXCR3, both in vitro and in HHcy mice. Importantly, the blockade of this axis, achieved through specific antibodies or NBI-74330, mitigated the detrimental effects of Hcy on endothelial function. In conclusion, our findings illuminated the central role of the CXCL10/CXCR3 axis in mediating Hcy-induced endothelial dysfunction, providing valuable insights for potential therapeutic strategies in managing HHcy-related cardiovascular diseases.
Subject(s)
Cardiovascular Diseases , Chemokine CXCL10 , Receptors, CXCR3 , Animals , Mice , Homocysteine/pharmacology , Up-Regulation , Chemokine CXCL10/metabolism , Receptors, CXCR3/metabolismABSTRACT
Elevated serum homocysteine (Hcy) level is a risk factor for Alzheimer's disease (AD) and accelerates cell aging. However, the mechanism by which Hcy induces neuronal senescence remains largely unknown. In this study, we observed that Hcy significantly promoted senescence in neuroblastoma 2a (N2a) cells with elevated ß-catenin and Kelch-like ECH-associated protein 1 (KEAP1) levels. Intriguingly, Hcy promoted the interaction between KEAP1 and the Wilms tumor gene on the X chromosome (WTX) while hampering the ß-catenin-WTX interaction. Mechanistically, Hcy attenuated the methylation level of the KEAP1 promoter CpG island and activated KEAP1 transcription. However, a slow degradation rate rather than transcriptional activation contributed to the high level of ß-catenin. Hcy-upregulated KEAP1 competed with ß-catenin to bind to WTX. Knockdown of both ß-catenin and KEAP1 attenuated Hcy-induced senescence in N2a cells. Our data highlight a crucial role of the KEAP1-ß-catenin pathway in Hcy-induced neuronal-like senescence and uncover a promising target for AD treatment.
Subject(s)
Cellular Senescence , Homocysteine , Kelch-Like ECH-Associated Protein 1 , Neuroblastoma , Ubiquitination , beta Catenin , beta Catenin/metabolism , Cellular Senescence/drug effects , Cellular Senescence/physiology , Animals , Homocysteine/pharmacology , Homocysteine/metabolism , Kelch-Like ECH-Associated Protein 1/metabolism , Mice , Cell Line, Tumor , Ubiquitination/drug effects , Neuroblastoma/metabolism , Humans , Neurons/metabolism , Neurons/drug effectsABSTRACT
Cerebrovascular dysfunction has been implicated as a major contributor to Alzheimer's Disease (AD) pathology, with cerebral endothelial cell (cEC) stress promoting ischemia, cerebral-blood flow impairments and blood-brain barrier (BBB) permeability. Recent evidence suggests that cardiovascular (CV)/cerebrovascular risk factors, including hyperhomocysteinemia (Hhcy), exacerbate AD pathology and risk. Yet, the underlying molecular mechanisms for this interaction remain unclear. Our lab has demonstrated that amyloid beta 40 (Aß40) species, and particularly Aß40-E22Q (AßQ22; vasculotropic Dutch mutant), promote death receptor 4 and 5 (DR4/DR5)-mediated apoptosis in human cECs, barrier permeability, and angiogenic impairment. Previous studies show that Hhcy also induces EC dysfunction, but it remains unknown whether Aß and homocysteine function through common molecular mechanisms. We tested the hypotheses that Hhcy exacerbates Aß-induced cEC DR4/5-mediated apoptosis, barrier dysfunction, and angiogenesis defects. This study was the first to demonstrate that Hhcy specifically potentiates AßQ22-mediated activation of the DR4/5-mediated extrinsic apoptotic pathway in cECs, including DR4/5 expression, caspase 8/9/3 activation, cytochrome-c release and DNA fragmentation. Additionally, we revealed that Hhcy intensifies the deregulation of the same cEC junction proteins mediated by Aß, precipitating BBB permeability. Furthermore, Hhcy and AßQ22, impairing VEGF-A/VEGFR2 signaling and VEGFR2 endosomal trafficking, additively decrease cEC angiogenic capabilities. Overall, these results show that the presence of the CV risk factor Hhcy exacerbates Aß-induced cEC apoptosis, barrier dysfunction, and angiogenic impairment. This study reveals specific mechanisms through which amyloidosis and Hhcy jointly operate to produce brain EC dysfunction and death, highlighting new potential molecular targets against vascular pathology in comorbid AD/CAA and Hhcy conditions.
Subject(s)
Amyloid beta-Peptides , Apoptosis , Blood-Brain Barrier , Endothelial Cells , Homocysteine , Humans , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Amyloid beta-Peptides/metabolism , Blood-Brain Barrier/drug effects , Blood-Brain Barrier/metabolism , Blood-Brain Barrier/pathology , Endothelial Cells/metabolism , Homocysteine/pharmacology , Homocysteine/metabolism , Hyperhomocysteinemia/metabolism , Hyperhomocysteinemia/complications , Neovascularization, Pathologic/metabolism , Receptors, TNF-Related Apoptosis-Inducing Ligand/metabolism , Receptors, TNF-Related Apoptosis-Inducing Ligand/geneticsABSTRACT
Homocysteine (Hcy) is an independent and serious risk factor for dementia, including Alzheimer's disease (AD), but the precise mechanisms are still poorly understood. In the current study, we observed that the permissive histone mark trimethyl histone H3 lysine 4 (H3K4me3) and its methyltransferase KMT2B were significantly elevated in hyperhomocysteinemia (HHcy) rats, with impairment of synaptic plasticity and cognitive function. Further research found that histone methylation inhibited synapse-associated protein expression, by suppressing histone acetylation. Inhibiting H3K4me3 by downregulating KMT2B could effectively restore Hcy-inhibited H3K14ace in N2a cells. Moreover, chromatin immunoprecipitation revealed that Hcy-induced H3K4me3 resulted in ANP32A mRNA and protein overexpression in the hippocampus, which was regulated by increased transcription Factor c-fos and inhibited histone acetylation and synapse-associated protein expression, and downregulating ANP32A could reverse these changes in Hcy-treated N2a cells. Additionally, the knockdown of KMT2B restored histone acetylation and synapse-associated proteins in Hcy-treated primary hippocampal neurons. These data have revealed a novel crosstalk mechanism between KMT2B-H3K4me3-ANP32A-H3K14ace, shedding light on its role in Hcy-related neurogenerative disorders.
Subject(s)
Histones , Hyperhomocysteinemia , Animals , Histones/metabolism , Hyperhomocysteinemia/metabolism , Hyperhomocysteinemia/complications , Hyperhomocysteinemia/pathology , Acetylation , Methylation/drug effects , Male , Rats, Sprague-Dawley , Hippocampus/metabolism , Hippocampus/pathology , Nuclear Proteins/metabolism , Nerve Degeneration/pathology , Nerve Degeneration/metabolism , Neurons/metabolism , Neurons/pathology , Rats , Synapses/metabolism , Synapses/pathology , Cell Line, Tumor , Homocysteine/metabolism , Homocysteine/pharmacologyABSTRACT
NEW FINDINGS: What is the central question of this study? What are the biggest challenges in performing in vitro studies on isolated human umbilical arteries? What is the main finding and its importance? The protocols presented in this study indicate some potential outcomes important for interpretation of the vascular responsivities of human umbilical arteries and could be useful for planning future in vitro studies with human umbilical arteries. ABSTRACT: Human umbilical artery (HUA) preparations are of particular importance for in vitro studies on isolated blood vessels because their sampling is not risky for the patient, and they can provide the closest possible impression of changes related to the uteroplacental circulation during pre-eclampsia. Using organ bath techniques, useful experimental protocols are provided for measuring some pathophysiological phenomena in the vascular responses of HUAs. Several vasoconstrictors (serotonin, prostaglandin F and phenylephrine) and vasodilators (acetylcholine and minoxidil) were seleted for determination of their vasoactivity in HUAs. The role of L-type voltage-operated calcium channels and different types of potassium channels (KATP , BKCa and KV ) were assessed, as was the impact of homocysteine. Serotonin was confirmed to be the most potent vasoconstrictor, while acetylcholine and phenylephrine caused variability in the relaxation and contraction response of HUA, respectively. The observed increase in serotonin-induced contraction and a decrease in minoxidil-induced relaxation in the presence of homocysteine suggested its procontractile effect on HUA preparations. Using selective blockers, it was determined that KATP and KV channels participate in the minoxidil-induced relaxation, while L-type voltage-dependent Ca2+ channels play an important role in the serotonin-induced contraction. The presented protocols reveal some of the methodological challenges related to HUA preparations and indicate potential outcomes in interpreting the vascular effects of the investigated substances, both in physiological conditions and in the homocysteine-induced pre-eclampsia model.
Subject(s)
Pre-Eclampsia , Umbilical Arteries , Pregnancy , Female , Humans , Umbilical Arteries/physiology , Serotonin , Acetylcholine/pharmacology , Minoxidil/pharmacology , Vasodilation/physiology , Vasoconstrictor Agents/pharmacology , Phenylephrine/pharmacology , Homocysteine/pharmacology , Adenosine Triphosphate/pharmacologyABSTRACT
Autophagy plays a critical role in the physiology and pathophysiology of hepatocytes. High level of homocysteine (Hcy) promotes autophagy in hepatocytes, but the underlying mechanism is still unknown. Here, we investigate the relationship between Hcy-induced autophagy level and the expression of nuclear transcription factor EB (TFEB). The results show that Hcy-induced autophagy level is mediated by upregulation of TFEB. Silencing of TFEB decreases the level of autophagy-related protein LC3BII/I and increases p62 expression level in hepatocytes after exposure to Hcy. Moreover, the effect of Hcy on the expression of TFEB is regulated by hypomethylation of the TFEB promoter catalyzed by DNA methyltransferase 3b (DNMT3b). In summary, this study shows that Hcy can activate autophagy by inhibiting DNMT3b-mediated DNA methylation and upregulating TFEB expression. These findings provide another new mechanism for Hcy-induced autophagy in hepatocytes.
Subject(s)
Autophagy , DNA Methylation , Hepatocytes , Homocysteine , Autophagy/genetics , DNA , Homocysteine/metabolism , Homocysteine/pharmacology , Humans , DNA Methyltransferase 3BABSTRACT
Abnormal elevation of homocysteine (Hcy) level accelerates atherosclerosis through promote macrophage inflammation, while the precise mechanisms remain to be well elucidated. Previous study revealed that Rap1A is involved in the development of atherosclerosis, but little is known regarding the regulation of macrophage inflammation induced by Hcy and its potential mechanisms. In the present study, we demonstrated that Hcy upregulates Rap1A expression and knockdown of Rap1A inhibited pro-inflammatory cytokines IL-6 and TNF-α levels in ANA-1 cells. Mechanistically, DNMT3a-mediated DNA hypomethylation of Rap1A promoter accelerates Hcy-induced ANA-1 cells inflammation. Furthermore, FoxO1 transcriptionally activate Rap1A by direct binding to its promoter. More importantly, Hcy could enhance FoxO1 interaction with DNMT3a and synergistically promote the expression of Rap1A resulting in accelerate ANA-1 cells inflammation. These data indicate that Rap1A is a novel and important regulator in Hcy-induced ANA-1 cells inflammation.
Subject(s)
Atherosclerosis , Homocysteine , Atherosclerosis/metabolism , Cells, Cultured , DNA Methylation , Forkhead Box Protein O1/metabolism , Homocysteine/pharmacology , Inflammation/genetics , rap1 GTP-Binding Proteins/genetics , rap1 GTP-Binding Proteins/metabolism , Animals , MiceABSTRACT
The aim of this study was to examine the effects of hyperhomocysteinemia and aerobic physical activity on changes of cardiovascular biomarkers in sera, oxidative stress in cardiac tissue, and histomorphometric parameters of heart and aorta in rats. Experiments were conducted on male Wistar albino rats organized into four groups (n = 10, per group): C (control group): 0.9% NaCl 0.2 mL/day; H (homocysteine group): homocysteine 0.45 µmol/g b.w./day; CPA (control + physical activity group): 0.9% NaCl 0.2 mL/day and a program of physical activity on a treadmill; and HPA (homocysteine + physical activity group) homocysteine 0.45 µmol/g b.w./day and a program of physical activity on a treadmill. Substances were applied subcutaneously twice a day. Lipid peroxidation and relative activity of Mn-superoxide dismutase isoform were significantly higher in active hyperhomocysteinemic rats in comparison to sedentary animals. Atherosclerotic plaques were detected in aorta samples of active hyperhomocysteinemic rats and also, they had increased left ventricle wall and interventricular septum, and transverse diameter of cardiomyocytes compared to sedentary groups. Aerobic physical activity in the condition of hyperhomocysteinemia can lead to increased oxidative stress in cardiac tissue and changes in histomorphometric parameters of the heart and aorta, as well increased lipid parameters and cardiac damage biomarkers in sera of rats.
Subject(s)
Hyperhomocysteinemia , Animals , Rats , Male , Saline Solution/pharmacology , Rats, Wistar , Oxidative Stress , Aorta/metabolism , Exercise , Biomarkers/metabolism , Homocysteine/pharmacologyABSTRACT
Abnormally high serum homocysteine levels have been associated with several disorders, including obesity, cardiovascular diseases or neurological diseases. Leptin is an anti-obesity protein and its action is mainly mediated by the activation of its Ob-R receptor in neuronal cells. The inability of leptin to induce activation of its specific signaling pathways, especially under endoplasmic reticulum stress, leads to the leptin resistance observed in obesity. The present study examined the effect of homocysteine on leptin signaling in SH-SY5Y neuroblastoma cells expressing the leptin receptor Ob-Rb. Phosphorylation of the signal transducer and activator of transcription (STAT3) and leptin-induced STAT3 transcriptional activity were significantly inhibited by homocysteine treatment. These effects may be specific to homocysteine and to the leptin pathway, as other homocysteine-related compounds, namely methionine and cysteine, have weak effect on leptin-induced inhibition of STAT3 phosphorylation, and homocysteine has no impact on IL-6-induced activation of STAT3. The direct effect of homocysteine on leptin-induced Ob-R activation, analyzed by Ob-R BRET biosensor to monitor Ob-R oligomerization and conformational change, suggested that homocysteine treatment does not affect early events of leptin-induced Ob-R activation. Instead, we found that, unlike methionine or cysteine, homocysteine increases the expression of the endoplasmic reticulum (ER) stress response gene, a homocysteine-sensitive ER resident protein. These results suggest that homocysteine may induce neuronal resistance to leptin by suppressing STAT3 phosphorylation downstream of the leptin receptor via ER stress.
Subject(s)
Leptin , Neuroblastoma , Humans , Leptin/metabolism , Receptors, Leptin/genetics , Homocysteine/pharmacology , Cysteine/pharmacology , Endoplasmic Reticulum Stress , STAT3 Transcription Factor/metabolism , Obesity/metabolism , Methionine/pharmacologyABSTRACT
OBJECTIVES: Hyperhomocysteinemia (HHcy) can induce vascular inflammatory and oxidative damage and accelerate intimal hyperplasia. This study investigated the protective effect of pirfenidone (PFD) on the recovery process of injured endothelial arteries during HHcy. MATERIALS AND METHODS: Thirty rabbits were randomly separated into three groups: A control group (n=10, standard rabbit chow), a model group (n=10, control diet plus 30 g methionine/kg food), and a PFD group (n=10, model diet plus oral administration of 90 mg/day of PFD). After 14 weeks of arterial injury, histopathological changes were determined. Plasma homocysteine (Hcy) concentrations, lipid profiles and oxidant and antioxidant status were evaluated. Macrophage infiltration was assessed using immunohistochemical staining. RESULTS: PFD supplementation decreased macrophage infiltration of iliac artery significantly without changes in blood lipids and Hcy concentrations. Compared with the model group, PFD restored superoxide dismutase and glutathione peroxidase activities and reduced malondialdehyde and reactive oxygen species levels. A high-methionine diet significantly increased neointimal area and the ratio between neointimal and media area. Systemic administration of PFD inhibited neointimal formation. CONCLUSIONS: PFD can partly alleviate intimal hyperplasia by inhibiting inflammatory and oxidative stress response induced by HHcy during endothelial injury. It may be a potential therapeutic agent for the prevention and treatment of endothelial injury-associated diseases such as atherosclerosis.
Subject(s)
Hyperhomocysteinemia , Animals , Antioxidants/pharmacology , Antioxidants/therapeutic use , Glutathione Peroxidase/pharmacology , Glutathione Peroxidase/therapeutic use , Homocysteine/pharmacology , Homocysteine/therapeutic use , Hyperhomocysteinemia/complications , Hyperhomocysteinemia/drug therapy , Hyperhomocysteinemia/pathology , Hyperplasia/pathology , Lipids , Malondialdehyde/pharmacology , Methionine/pharmacology , Methionine/therapeutic use , Oxidants/pharmacology , Oxidants/therapeutic use , Pyridones , Rabbits , Reactive Oxygen Species/pharmacology , Reactive Oxygen Species/therapeutic use , Superoxide Dismutase/pharmacology , Superoxide Dismutase/therapeutic use , Tunica Intima/pathologyABSTRACT
Objective To explore the role of microRNA-488-3p (miR-488-3p) in podocytes apoptosis induced by homocysteine (Hcy). Methods Flow cytometry was employed to analyze the ratio of podocytes apoptosis after treated with 0 µmol/L Hcy (control group) or 80 µmol/L Hcy (Hcy group) for 48 hours. The expression levels of B-cell lymphoma 2 (Bcl2), Bcl2-related X protein (BAX), and caspase-3 were measured by Western blot analysis in podocytes, after cells were treated with 80 µmol/L Hcy (Hcy group) for 48 hours, and the expression of miR-488-3p was detected by real-time PCR. The transfection and apoptosis ratio of podocytes were also detected after cells were transfected with miR-488-3p inhibitor. Results The apoptosis rate of podocytes increased in cells treated with Hcy, compared with control group. The expression levels of BAX and caspase-3 increased significantly in Hcy group, while Bcl2 expression was suppressed by Hcy. Furthermore, the expression of miR-488-3p increased in Hcy-induced podocyte. On the contrary, podocyte showed an decreased apoptosis rate, expression levels of BAX and caspase-3 decreased after cells were transfected with miR-488-3p inhibitor. However, Bcl2, which was not in this line, showed an increase when the cells transfected with miR-488-3p inhibitor. Conclusion Hcy promotes apoptosis of podocyte by up-regulating the expression of miR-488-3p.
Subject(s)
Apoptosis , Homocysteine , MicroRNAs , Podocytes , Animals , Caspase 3/genetics , Caspase 3/metabolism , Homocysteine/pharmacology , Mice , MicroRNAs/genetics , MicroRNAs/metabolism , Podocytes/metabolism , Podocytes/pathology , Up-Regulation , bcl-2-Associated X Protein/genetics , bcl-2-Associated X Protein/metabolismABSTRACT
Objective To investigate the role of activating molecule in beclin-1-regulated autophage (AMBRA1) in homocysteine (Hcy)-induced hepatocytes autophagy. Methods Hepatocytes were cultured in vitro and divided into control group (0 µmol/L Hcy) and Hcy treatment group (100 µmol/L Hcy). Western blotting was used to detect the expression of microtubule-associated protein 1 light chain 3B (LC3BII, LC3BI); hepatocytes were treated with 0, 25, 50, 100 µmol/L chloroquine (CQ), CCK-8 assay was used to detect the inhibitory effect of CQ on hepatocyte proliferation and Western blotting was performed to detect the expression of LC3B and AMBRA1; After hepatocytes were transfected with AMBRA1 small interfering RNA, real-time fluorescent quantitative PCR and Western blotting were used to detect the interference efficiency of AMBRA1 expression; After the transfected hepatocytes were treated with Hcy, the expression of LC3B was detected by Western blot analysis. mRFP-GFP-LC3 adenovirus was transfected with hepatocytes and the autophagy flow was observed by laser scanning confocal microscopy. Results Compared with the control group, the ratio of LC3BII/LC3BIincreased in the Hcy treatment group; the inhibition rate of 50 µmol/L CQ on hepatocyte proliferation was close to 50%; compared with the control group, the ratio of LC3BII/LC3BI and the expression of AMBRA1 increased significantly in the Hcy group , and the ratio of LC3BII/LC3BI and the expression of AMBRA1 in the Hcy combined with CQ group were significantly lower than those in the Hcy group; the ratio of LC3BII/LC3BI decreased after knocking down AMBRA1; compared with the control group, the autophagosomes and autophagolysosomes increased in Hcy group and decreased after knocking down AMBRA1. Conclusion Hcy can promote hepatocyte autophagy by activating AMBRA1.
Subject(s)
Adaptor Proteins, Signal Transducing , Autophagy , Homocysteine , Adaptor Proteins, Signal Transducing/genetics , Autophagosomes/metabolism , Hepatocytes/metabolism , Homocysteine/pharmacology , HumansABSTRACT
Background: There is a growing interest in the use of natural compounds for the treatment of gastric ulcers. The multifunctional roles of betaine in various diseases make this natural substance a favorable pre-drug for ulcer treatment. This study aims to determine the competence of betaine in gastroprotection against ethanol-induced damage and to explore underlying mechanisms considering its effects on liver and kidney activity and blood parameters.Methods: Wistar albino rats were orally treated with vehicle (distilled water) or betaine (250 mg/kg) for twenty-one days and then ulcer formation was induced by ingestion of 75% ethanol. Gastric mucosal damage was evaluated by gross examination and histopathological analysis. Homocysteine levels, lipid peroxidation, total antioxidant status (TAS), total oxidant status (TAS), antioxidant enzymes and pro-inflammatory and anti-inflammatory cytokines levels were assessed by enzyme-linked immunosorbent assay (ELISA) or immunohistochemistry. Furthermore, routine biochemical tests were performed and hematological parameters were analyzed.Results: Betaine ameliorated any gastric mucosal damage and reduced homocysteine levels significantly. The TOS and malondialdehyde (MDA) levels were decreased while the TAS, glutathione (GSH) levels and catalase (CAT) activity were increased upon the betaine treatment. Betaine reduced apoptosis by regulating Bax and Bcl-2 levels, however, it did not alter inflammatory mediators. Additionally, betaine improved serum potassium (K+) and blood urea nitrogen (BUN) levels, whereas it increased alanine aminotransferase (ALT) levels and impaired hematological parameters.Conclusions: Altogether, these data illustrated that betaine exhibits a gastroprotective effect against ulcers through the homocysteine pathway by modulating oxidative stress in the gastric tissue; however, its systemic effects should not be ignored.